8-K - Stabilis Solutions, Inc. (0001043186) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Stabilis Solutions filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- SLNG Stabilis Solutions
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Silence Therapeutics belongs to, so it often moves with news about it.
- NVS Novartis AG+1.5% 15d
Novartis AG is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+12.6% 30d
AstraZeneca is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- NVO Novo Nordisk A/S-7.3% 30d
Novo Nordisk A/S is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- GSK Gsk-6.8% 8d
Gsk is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- SNY Sanofi
Sanofi is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| SLNG | +2.30% | +0.00% | base | after close | after close | after close | after close |
| XLV | -2.96% | -2.66% | base | after close | after close | after close | after close |
| NVS | -2.40% | -2.15% | base | after close | after close | after close | after close |
| AZN | -7.67% | -1.27% | base | after close | after close | after close | after close |
| NVO | -7.15% | -4.07% | base | after close | after close | after close | after close |
| GSK | -4.85% | -3.95% | base | after close | after close | after close | after close |
| SNY | -9.10% | -4.03% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0001437749-26-034943 Size: 642 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Stabilis Solutions (SLNG)
| Company | When | Move | Status |
|---|---|---|---|
| Astrazeneca (AZN) | three days earlier | -1.27% | final price |
| Astrazeneca (AZN) | five days earlier | -7.67% | final price |
| Gsk (GSK) | three days earlier | -3.95% | final price |
| Gsk (GSK) | five days earlier | -4.85% | final price |
| Novo Nordisk A S (NVO) | three days earlier | -4.07% | final price |
| Novo Nordisk A S (NVO) | five days earlier | -7.15% | final price |
| Novartis Ag (NVS) | three days earlier | -2.15% | final price |
| Novartis Ag (NVS) | five days earlier | -2.40% | final price |
| Stabilis Solutions (SLNG) | three days earlier | 0.00% | final price |
| Stabilis Solutions (SLNG) | five days earlier | +2.30% | final price |
| Sanofi (SNY) | three days earlier | -4.03% | final price |
| Sanofi (SNY) | five days earlier | -9.10% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.66% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.96% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 69 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 55 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 65 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 70 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Stabilis Solutions (SLNG)
Companies tied to this story
- SLNG Stabilis Solutions
For “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Stabilis Solutions (SLNG) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SLNG
- XLV Select Sector Spdr Tr
For “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Silence Therapeutics belongs to, so it often moves with news about it
- NVS Novartis Ag
In “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Novartis Ag (NVS) is linked, with no stored direction, medium confidence. Reason on file: Novartis AG is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news
- AZN Astrazeneca
In “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Astrazeneca (AZN) is linked, with no stored direction, medium confidence. Reason on file: AstraZeneca is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news
- NVO Novo Nordisk A S
For “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Novo Nordisk A S (NVO) is linked, with no stored direction, medium confidence. Reason on file: Novo Nordisk A/S is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news
- GSK Gsk
For “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Gsk (GSK) is linked, with no stored direction, medium confidence. Reason on file: Gsk is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news
- SNY Sanofi
In “8-K - Stabilis Solutions, Inc. (0001043186) (Filer),” Sanofi (SNY) is linked, with no stored direction, medium confidence. Reason on file: Sanofi is a peer of Silence Therapeutics in pharmaceutical preparations; rivals often move on the same news
How “8-K - Stabilis Solutions, Inc. (0001043186) (Filer)” reaches Stabilis Solutions (SLNG)
“8-K - Stabilis Solutions, Inc. (0001043186) (Filer)” (4 Nov 2026) reaches Stabilis Solutions (SLNG) through this story.
What ties Stabilis Solutions (SLNG) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> SLNG
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Silence Therapeutics belongs to, so it often moves with news about it
Dates and price levels for Stabilis Solutions (SLNG)
NVS traded between 139.43 and 147.02 across 12 sessions. The latest close on file is 140.78.
How strong the case is around Stabilis Solutions (SLNG)
46 out of 100
“8-K - Stabilis Solutions, Inc. (0001043186) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.